{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:59:58Z","timestamp":1791158398534,"version":"4.1.0"},"reference-count":118,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.cjca.2012.11.032","type":"journal-article","created":{"date-parts":[[2013,1,23]],"date-time":"2013-01-23T03:26:13Z","timestamp":1358911573000},"page":"151-167","source":"Crossref","is-referenced-by-count":494,"title":["2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult"],"prefix":"10.1016","volume":"29","author":[{"given":"Todd J.","family":"Anderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Gr\u00e9goire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Hegele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Couture","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.B. John","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"McPherson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon A.","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Grover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Jacques","family":"Genest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 C.","family":"Carpentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence A.","family":"Leiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Lonn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic S.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen J.","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian M.","family":"Yates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehud","family":"Ur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2012.11.032_bib1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0828-282X(09)70715-9","article-title":"2009 Canadian Cardiovascular Society\/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations","volume":"25","author":"Genest","year":"2009","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2012.11.032_bib2","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.cjca.2012.11.032_bib3","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2012.11.032_bib4","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (study of heart and renal protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2012.11.032_bib5","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(12)60572-8","article-title":"Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study","volume":"380","author":"Tonelli","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2012.11.032_bib6","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"ESC\/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"32","author":"Reiner","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2012.11.032_bib7","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1161\/CIRCULATIONAHA.110.986349","article-title":"Cost-effectiveness of statin therapy for primary prevention in a low-cost statin era","volume":"124","author":"Lazar","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2012.11.032_bib8","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cjca.2011.05.007","article-title":"Diagnosis, prevention, and management of statin adverse effects and intolerance: proceedings of a Canadian working group consensus conference","volume":"27","author":"Mancini","year":"2011","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2012.11.032_bib9","doi-asserted-by":"crossref","first-page":"E1135","DOI":"10.1503\/cmaj.101508","article-title":"Harmonization of guidelines for the prevention and treatment of cardiovascular disease: the C-CHANGE initiative","volume":"183","author":"Tobe","year":"2011","journal-title":"CMAJ"},{"key":"10.1016\/j.cjca.2012.11.032_bib10","first-page":"2167","article-title":"Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis","volume":"33","author":"Han","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cjca.2012.11.032_bib11","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.24836","article-title":"Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease?","volume":"61","author":"Peters","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cjca.2012.11.032_bib12","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cjca.2010.12.040","article-title":"Chronic inflammatory diseases and cardiovascular risk: a systematic review","volume":"27","author":"Roifman","year":"2011","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2012.11.032_bib13","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/1529-0131(199902)42:2<338::AID-ANR17>3.0.CO;2-U","article-title":"Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus","volume":"42","author":"Ward","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cjca.2012.11.032_bib14","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1002\/art.11241","article-title":"Hospitalizations for coronary artery disease among patients with systemic lupus erythematosus","volume":"48","author":"Thorburn","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cjca.2012.11.032_bib15","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/ard.2008.094839","article-title":"Cardiovascular morbidity in psoriatic arthritis","volume":"68","author":"Gladman","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cjca.2012.11.032_bib16","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1378\/chest.128.4.2068","article-title":"COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser permanente medical care program","volume":"128","author":"Sidney","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.cjca.2012.11.032_bib17","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1056\/NEJMoa022048","article-title":"Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection","volume":"348","author":"Bozzette","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2012.11.032_bib18","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa062744","article-title":"Class of antiretroviral drugs and the risk of myocardial infarction","volume":"356","author":"Friis-Moller","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2012.11.032_bib19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0140-6736(00)02456-9","article-title":"Premature cardiovascular disease in chronic renal failure","volume":"356","author":"Baigent","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2012.11.032_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ahj.2012.04.006","article-title":"Prognostic utility of erectile dysfunction for cardiovascular disease in younger men and those with diabetes","volume":"164","author":"Miner","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2012.11.032_bib21","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome-a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2012.11.032_bib22","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/archinternmed.2009.516","article-title":"The effect of giving global coronary risk information to adults: a systematic review","volume":"170","author":"Sheridan","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cjca.2012.11.032_bib23","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jacc.2009.07.020","article-title":"Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians","volume":"54","author":"Cooney","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2012.11.032_bib24","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1001\/archinte.167.21.2296","article-title":"Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy: the CHECK-UP study: a randomized controlled trial","volume":"167","author":"Grover","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cjca.2012.11.032_bib25","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0828-282X(07)70786-9","article-title":"Preventing cardiovascular disease among Canadians: what are the potential benefits of treating hypertension or dyslipidemia?","volume":"23","author":"Grover","year":"2007","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2012.11.032_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001561.pub3","article-title":"Multiple risk factor interventions for primary prevention of coronary heart disease","author":"Ebrahim","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cjca.2012.11.032_bib27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1472-6963-12-20","article-title":"Use of global coronary heart disease risk assessment in practice: a cross-sectional survey of a sample of U.S. physicians","volume":"12","author":"Shillinglaw","year":"2012","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.cjca.2012.11.032_bib28","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cjca.2011.09.014","article-title":"Perceptions of Canadian primary care physicians towards cardiovascular risk assessment and lipid management","volume":"28","author":"Gupta","year":"2012","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2012.11.032_bib29","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D'Agostino","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2012.11.032_bib30","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1001\/jama.291.18.2204","article-title":"Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring","volume":"291","author":"Lloyd-Jones","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2012.11.032_bib31","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(07)61778-4","article-title":"Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths","volume":"370","author":"Lewington","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2012.11.032_bib32","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1001\/archinte.1994.00420150063006","article-title":"Life expectancy following dietary modification or smoking cessation","volume":"154","author":"Grover","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cjca.2012.11.032_bib33","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.jacc.2003.11.061","article-title":"The distribution of 10-year risk for coronary heart disease among US adults: findings from the National Health and Nutrition Examination Survey III","volume":"43","author":"Ford","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2012.11.032_bib34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cjca.2010.12.025","article-title":"The effect of the change in the Framingham risk score calculator between the 2006 and 2009 Canadian lipid guidelines","volume":"27","author":"Armstrong","year":"2011","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2012.11.032_bib35","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1001\/archinte.167.21.2286","article-title":"Prediction is difficult, particularly about the future","volume":"167","author":"Jackson","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cjca.2012.11.032_bib36","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/HJR.0b013e328337ccd3","article-title":"Evaluation of a cardiovascular disease risk assessment tool for the promotion of healthier lifestyles","volume":"17","author":"Soureti","year":"2010","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.cjca.2012.11.032_bib37","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1136\/bmj.310.6985.975","article-title":"Do doctors accurately assess coronary risk in their patients?","volume":"310","author":"Grover","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.cjca.2012.11.032_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2012.05.007","volume":"223","author":"Perk","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cjca.2012.11.032_bib39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11606-008-0825-4","article-title":"Discussing coronary risk with patients to improve blood pressure treatment: secondary results from the CHECK-UP study","volume":"24","author":"Grover","year":"2009","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.cjca.2012.11.032_bib40","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jama.288.4.462","article-title":"Adherence with statin therapy in elderly patients with and without acute coronary syndromes","volume":"288","author":"Jackevicius","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2012.11.032_bib41","doi-asserted-by":"crossref","first-page":"208","DOI":"10.5694\/j.1326-5377.1996.tb94138.x","article-title":"Apparent discontinuation rates in patients prescribed lipid-lowering drugs","volume":"164","author":"Simons","year":"1996","journal-title":"Med J Aust"},{"key":"10.1016\/j.cjca.2012.11.032_bib42","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cjca.2011.01.016","article-title":"Identification and management of cardiometabolic risk in Canada: a position paper by the cardiometabolic risk working group (executive summary)","volume":"27","author":"Leiter","year":"2011","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2012.11.032_bib43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1464-5491.2010.03157.x","article-title":"Combined cardiovascular and diabetes risk assessment in primary care","volume":"28","author":"Preiss","year":"2011","journal-title":"Diabet Med"},{"key":"10.1016\/j.cjca.2012.11.032_bib44","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2012.11.032_bib45","doi-asserted-by":"crossref","first-page":"e34287","DOI":"10.1371\/journal.pone.0034287","article-title":"Framingham risk score and alternatives for prediction of coronary heart disease in older adults","volume":"7","author":"Rodondi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cjca.2012.11.032_bib46","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Mihaylova","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2012.11.032_bib47","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2012.11.032_bib48","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS\/TexCAPS","volume":"279","author":"Downs","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2012.11.032_bib49","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia","volume":"333","author":"Shepherd","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2012.11.032_bib50","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","volume":"361","author":"Sever","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2012.11.032_bib51","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCOUTCOMES.110.959247","article-title":"A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk","volume":"4","author":"Sniderman","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.cjca.2012.11.032_bib52","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/CIRCULATIONAHA.105.567107","article-title":"Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study","volume":"113","author":"Kathiresan","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2012.11.032_bib53","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1001\/jama.2012.366","article-title":"Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis","volume":"307","author":"Boekholdt","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2012.11.032_bib54","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2012.11.032_bib55","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2012.11.032_bib56","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa050461","article-title":"Intensive lipid lowering with atorvastatin in patients with stable coronary disease","volume":"352","author":"LaRosa","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2012.11.032_bib57","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1161\/CIRCULATIONAHA.105.586347","article-title":"A tale of two trials: a comparison of the post-acute coronary syndrome lipid-lowering trials A to Z and PROVE IT-TIMI 22","volume":"113","author":"Wiviott","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2012.11.032_bib58","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1001\/jama.294.19.2437","article-title":"High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial","volume":"294","author":"Pedersen","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2012.11.032_bib59","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0140-6736(10)60310-8","article-title":"Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial","volume":"376","author":"Armitage","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2012.11.032_bib60","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/00041433-199512000-00010","article-title":"Percentage change rather than plasma level of LDL-cholesterol determines therapeutic response in coronary heart disease","volume":"6","author":"Thompson","year":"1995","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.cjca.2012.11.032_bib61","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1196\/annals.1383.013","article-title":"Pathogenesis of thoracic and abdominal aortic aneurysms","volume":"1085","author":"Guo","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cjca.2012.11.032_bib62","doi-asserted-by":"crossref","first-page":"e266","DOI":"10.1161\/CIR.0b013e3181d4739e","volume":"121","author":"Hiratzka","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2012.11.032_bib63","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"issue":"suppl 1","key":"10.1016\/j.cjca.2012.11.032_bib64","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.atherosclerosis.2011.06.012","article-title":"ESC\/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"217","author":"Catapano","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cjca.2012.11.032_bib65","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"Boden","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2012.11.032_bib66","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1056\/NEJMoa1001282","article-title":"Effects of combination lipid therapy in type 2 diabetes mellitus","volume":"362","author":"Ginsberg","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2012.11.032_bib67","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/j.jacc.2010.09.001","article-title":"2010 ACCF\/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines","volume":"56","author":"Greenland","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2012.11.032_bib68","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1177\/2047487312450228","volume":"19","year":"2012","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.cjca.2012.11.032_bib69","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with lp(a) lipoprotein level and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2012.11.032_bib70","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2009.801","article-title":"Genetically elevated lipoprotein(a) and increased risk of myocardial infarction","volume":"301","author":"Kamstrup","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2012.11.032_bib71","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","author":"Erqou","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2012.11.032_bib72","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","article-title":"C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis","volume":"375","author":"Kaptoge","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2012.11.032_bib73","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa0707402","article-title":"Genetically elevated C-reactive protein and ischemic vascular disease","volume":"359","author":"Zacho","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2012.11.032_bib74","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/ije\/dyn217","article-title":"Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts","volume":"38","author":"Shah","year":"2009","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.cjca.2012.11.032_bib75","doi-asserted-by":"crossref","first-page":"413","DOI":"10.7326\/0003-4819-141-6-200409210-00006","article-title":"Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk","volume":"141","author":"Khaw","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cjca.2012.11.032_bib76","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJMoa0908359","article-title":"Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults","volume":"362","author":"Selvin","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2012.11.032_bib77","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1371\/journal.pmed.0050207","article-title":"The relationship between proteinuria and coronary risk: a systematic review and meta-analysis","volume":"5","author":"Perkovic","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.cjca.2012.11.032_bib78","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.atherosclerosis.2007.07.029","article-title":"Cardiovascular and mortality risk prediction and stratification using urinary albumin excretion in older adults ages 68-102: the Cardiovascular Health Study","volume":"197","author":"Cao","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cjca.2012.11.032_bib79","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMoa011858","article-title":"Exercise capacity and mortality among men referred for exercise testing","volume":"346","author":"Myers","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2012.11.032_bib80","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1161\/01.CIR.0000143226.40607.71","article-title":"Usefulness of exercise testing in the prediction of coronary disease risk among asymptomatic persons as a function of the Framingham Risk Score","volume":"110","author":"Balady","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2012.11.032_bib81","doi-asserted-by":"crossref","first-page":"821","DOI":"10.7326\/0003-4819-147-12-200712180-00001","article-title":"An externally validated model for predicting long-term survival after exercise treadmill testing in patients with suspected coronary artery disease and a normal electrocardiogram","volume":"147","author":"Lauer","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cjca.2012.11.032_bib82","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1001\/jama.292.12.1462","article-title":"Global risk scores and exercise testing for predicting all-cause mortality in a preventive medicine program","volume":"292","author":"Aktas","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2012.11.032_bib83","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1056\/NEJMcp023197","article-title":"Clinical practice","volume":"349","author":"Greenland","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2012.11.032_bib84","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1161\/CIRCULATIONAHA.106.628875","article-title":"Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis","volume":"115","author":"Lorenz","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2012.11.032_bib85","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.jacc.2009.11.075","article-title":"Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk in Communities) study","volume":"55","author":"Nambi","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2012.11.032_bib86","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1001\/jama.2012.9630","article-title":"Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis","volume":"308","author":"Den Ruijter","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2012.11.032_bib87","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.300.2.197","article-title":"Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis","volume":"300","author":"Fowkes","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2012.11.032_bib88","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jacc.2006.10.001","volume":"49","author":"Greenland","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2012.11.032_bib89","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJMoa072100","article-title":"Coronary calcium as a predictor of coronary events in four racial or ethnic groups","volume":"358","author":"Detrano","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2012.11.032_bib90","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0140-6736(11)60784-8","article-title":"Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study","volume":"378","author":"Blaha","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2012.11.032_bib91","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1001\/archinte.167.22.2437","article-title":"Coronary artery calcium scores and risk for cardiovascular events in women classified as \u201clow risk\u201d based on Framingham Risk Score: the multi-ethnic study of atherosclerosis (MESA)","volume":"167","author":"Lakoski","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cjca.2012.11.032_bib92","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/jama.291.2.210","article-title":"Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals","volume":"291","author":"Greenland","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2012.11.032_bib93","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1001\/jama.2010.461","article-title":"Coronary artery calcium score and risk classification for coronary heart disease prediction","volume":"303","author":"Polonsky","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2012.11.032_bib94","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jacc.2010.06.029","article-title":"Coronary calcium score improves classification of coronary heart disease risk in the elderly: the Rotterdam study","volume":"56","author":"Elias-Smale","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2012.11.032_bib95","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jacc.2010.06.030","article-title":"Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: The Heinz Nixdorf Recall study","volume":"56","author":"Erbel","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2012.11.032_bib96","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jama.2012.9624","article-title":"Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals","volume":"308","author":"Yeboah","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2012.11.032_bib97","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2012.11.032_bib98","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/ajcn\/69.4.632","article-title":"Effects of the national cholesterol education program's step I and step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis","volume":"69","author":"Yu-Poth","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.cjca.2012.11.032_bib99","series-title":"Canadian Guidelines for Cardiac Rehabilitation and Cardiovascular Disease Prevention: Translating Knowledge into Action","year":"2009"},{"key":"10.1016\/j.cjca.2012.11.032_bib100","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1001\/archinte.167.22.2453","article-title":"Physical activity recommendations and decreased risk of mortality","volume":"167","author":"Leitzmann","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cjca.2012.11.032_bib101","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1503\/cmaj.051351","article-title":"Health benefits of physical activity: the evidence","volume":"174","author":"Warburton","year":"2006","journal-title":"CMAJ"},{"key":"10.1016\/j.cjca.2012.11.032_bib102","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1001\/archinte.167.10.999","article-title":"Effect of aerobic exercise training on serum levels of high-density lipoprotein cholesterol: a meta-analysis","volume":"167","author":"Kodama","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cjca.2012.11.032_bib103","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/S0140-6736(11)60749-6","article-title":"Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study","volume":"378","author":"Wen","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2012.11.032_bib104","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1139\/H11-009","article-title":"New Canadian physical activity guidelines","volume":"36","author":"Tremblay","year":"2011","journal-title":"Appl Physiol Nutr Metab"},{"key":"10.1016\/j.cjca.2012.11.032_bib105","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1056\/NEJMp1106689","article-title":"Weighing the benefits of high-dose simvastatin against the risk of myopathy","volume":"365","author":"Egan","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2012.11.032_bib106","doi-asserted-by":"crossref","first-page":"610","DOI":"10.4088\/JCP.11m07038","article-title":"Statin use and risk of depression in patients with coronary heart disease: longitudinal data from the heart and soul study","volume":"73","author":"Otte","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.cjca.2012.11.032_bib107","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/archneurol.2011.1060","article-title":"Prospective study of statin use and risk of Parkinson disease","volume":"69","author":"Gao","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.cjca.2012.11.032_bib108","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1161\/STROKEAHA.112.655894","article-title":"Statin therapy and the risk of intracerebral hemorrhage: a meta-analysis of 31 randomized controlled trials","volume":"43","author":"McKinney","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.cjca.2012.11.032_bib109","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.amjcard.2010.09.031","article-title":"Effects of maximal atorvastatin and rosuvastatin treatment on markers of glucose homeostasis and inflammation","volume":"107","author":"Thongtang","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2012.11.032_bib110","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1742-1241.2011.02779.x","article-title":"Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin\/ezetimibe on parameters of insulin resistance","volume":"65","author":"Moutzouri","year":"2011","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.cjca.2012.11.032_bib111","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.cjca.2012.03.021","article-title":"Statin use and the risk of incident diabetes mellitus: a review of the literature","volume":"28","author":"Colbert","year":"2012","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2012.11.032_bib112","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(12)61190-8","article-title":"Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial","volume":"380","author":"Ridker","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2012.11.032_bib113","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.jacc.2010.10.047","article-title":"Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials","volume":"57","author":"Waters","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2012.11.032_bib114","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/clpt.2011.83","article-title":"Detecting drug interactions from adverse-event reports: interaction between paroxetine and pravastatin increases blood glucose levels","volume":"90","author":"Tatonetti","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cjca.2012.11.032_bib115","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jacl.2011.03.454","article-title":"Efficacy and tolerability of once-weekly rosuvastatin in patients with previous statin intolerance","volume":"5","author":"Kennedy","year":"2011","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.cjca.2012.11.032_bib116","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1185\/03007995.2011.598144","article-title":"Vitamin D deficiency, myositis-myalgia, and reversible statin intolerance","volume":"27","author":"Glueck","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.cjca.2012.11.032_bib117","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0735-1097(86)80293-5","article-title":"Fifteen year mortality in coronary drug project patients: long-term benefit with niacin","volume":"8","author":"Canner","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2012.11.032_bib118","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1056\/NEJM199908053410604","article-title":"Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol","volume":"341","author":"Rubins","year":"1999","journal-title":"N Engl J Med"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X12015103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X12015103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T15:24:34Z","timestamp":1562599474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X12015103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":118,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0828282X12015103"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2012.11.032","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}